Ernexa Therapeutics Inc. Warrants reported earnings of per ERNAW share on Nov 11, 2026, falling short of analysts' expectations by
| Report Date | Nov 11, 2026 |
|---|---|
| Forecasted EPS | -$ 3.84 |
| Last Year's EPS | -$ 4.81 |
| EPS YoY Change |
Out of the last 10 earnings reporting periods, Ernexa Therapeutics Inc. Warrants beat analysts’ expectations 6 times and fell short of expectations 3 time(s). Ernexa Therapeutics Inc. Warrants reported earnings per share of in the last report surpassing an estimated EPS of -$ 3.84 by
| Report Date | Forecasted EPS | Reported EPS | Last Year's EPS | EPS YoY Change |
|---|---|---|---|---|
| Nov 11, 2026 | -$ 3.84 | - | - | |
| Nov 6, 2026 | -$ 3.84 | -$ 1.89 | -$ 900.00 | |
| Aug 17, 2026 | -$ 3.30 | -$ 12,750 | - | |
| Aug 6, 2026 | -$ 3.30 | -$ 3.30 | - | - |
| May 11, 2026 | -$ 1.95 | -$ 6.95 | - | - |
| Mar 13, 2026 | -$ 1.95 | -$ 4.81 | - | - |
| Mar 20, 2023 | -$ 900.00 | -$ 465.00 | - | - |
| Nov 14, 2022 | -$ 825.00 | - | - | |
| Jul 1, 2022 | -$ 1,200.00 | -$ 900.00 | - | - |
| Nov 9, 2021 | -$ 600.00 | -$ 12,750 | - | - |
Ernexa Therapeutics Inc. Warrants’s stock was trading at $ 0.0258 on Nov 10, 2026 a day before the last earnings report was released.Following the release of the earnings report, ERNAW’s price decreased to $ 0.0257 on Nov 12, 2026, recording a
| Report Date | EPS | Price 1 Day Before | Price 1 Day After | Change |
|---|---|---|---|---|
| Nov 11, 2026 | | $ 0.0258 | $ 0.0257 | |
| Nov 6, 2026 | -$ 1.89 | $ 0.0256 | $ 0.0262 | |
| Aug 17, 2026 | | $ 0.05020 | $ 0.05 | |
| Aug 6, 2026 | -$ 3.30 | $ 0.0431 | $ 0.038 | |
| May 11, 2026 | -$ 6.95 | $ 0.075 | $ 0.1365 | |
| Mar 13, 2026 | -$ 4.81 | $ 0.08 | $ 0.038 |
Ernexa Therapeutics Inc. Warrants released its most recent earnings reports in November 2026, November 2026, August 2026, August 2026 respectively. Generally, most companies have a consistent schedule for their earnings releases. However, companies do not necessarily release their earnings reports at the same time each year. The timing of earnings releases can vary depending on a company's fiscal year, industry norms, and internal reporting practices.
Ernexa Therapeutics Inc. Warrants beat analysts’ expectations during the last earnings period by
